BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 1558183)

  • 1. Role of nitric oxide in vasopressinergic pulmonary vasodilatation.
    Russ RD; Walker BR
    Am J Physiol; 1992 Mar; 262(3 Pt 2):H743-7. PubMed ID: 1558183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the vasodilatory action of testosterone in the human pulmonary circulation.
    Smith AM; Bennett RT; Jones TH; Cowen ME; Channer KS; Jones RD
    Vasc Health Risk Manag; 2008; 4(6):1459-66. PubMed ID: 19337559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early vasopressin infusion improves oxygenation in infants with congenital diaphragmatic hernia.
    Capolupo I; De Rose DU; Mazzeo F; Monaco F; Giliberti P; Landolfo F; Di Pede A; Toscano A; Conforti A; Bagolan P; Dotta A
    Front Pediatr; 2023; 11():1104728. PubMed ID: 37063685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Heart as a Target of Vasopressin and Other Cardiovascular Peptides in Health and Cardiovascular Diseases.
    Szczepanska-Sadowska E
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Paraventricular Nucleus of the Hypothalamus in Control of Blood Pressure and Blood Pressure Variability.
    Savić B; Murphy D; Japundžić-Žigon N
    Front Physiol; 2022; 13():858941. PubMed ID: 35370790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposing responses of the rat pulmonary artery and vein to phenylephrine and other agents in vitro.
    Liao LM; Zhou L; Wang CR; Hu JY; Lu YJ; Huang S
    BMC Pulm Med; 2021 Jun; 21(1):189. PubMed ID: 34090386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasopressin & Oxytocin in Control of the Cardiovascular System: An Updated Review.
    Japundžić-Žigon N; Lozić M; Šarenac O; Murphy D
    Curr Neuropharmacol; 2020; 18(1):14-33. PubMed ID: 31544693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Terlipressin versus norepinephrine to prevent milrinone-induced systemic vascular hypotension in cardiac surgery patient with pulmonary hypertension.
    Abdelazziz MM; Abdelhamid HM
    Ann Card Anaesth; 2019; 22(2):136-142. PubMed ID: 30971593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of vasopressin during a pulmonary hypertensive crisis induced by acute hypoxia in a rat model of pulmonary hypertension.
    Sugawara Y; Mizuno Y; Oku S; Goto T
    Br J Anaesth; 2019 Apr; 122(4):437-447. PubMed ID: 30857600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of pulmonary hypertension and right heart failure in the intensive care unit.
    Grinstein J; Gomberg-Maitland M
    Curr Hypertens Rep; 2015 May; 17(5):32. PubMed ID: 25833459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Perioperative management in patients with pulmonary hypertension.
    Tonelli AR; Minai OA
    Ann Thorac Med; 2014 Jul; 9(Suppl 1):S98-S107. PubMed ID: 25077004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasopressin improves hemodynamic status in infants with congenital diaphragmatic hernia.
    Acker SN; Kinsella JP; Abman SH; Gien J
    J Pediatr; 2014 Jul; 165(1):53-58.e1. PubMed ID: 24840762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasopressin and oxytocin in control of the cardiovascular system.
    Japundžić-Žigon N
    Curr Neuropharmacol; 2013 Mar; 11(2):218-30. PubMed ID: 23997756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of acute right ventricular failure in the intensive care unit.
    Green EM; Givertz MM
    Curr Heart Fail Rep; 2012 Sep; 9(3):228-35. PubMed ID: 22805893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bench-to-bedside review: Vasopressin in the management of septic shock.
    Russell JA
    Crit Care; 2011 Aug; 15(4):226. PubMed ID: 21892977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered membrane lipid domains limit pulmonary endothelial calcium entry following chronic hypoxia.
    Paffett ML; Naik JS; Riddle MA; Menicucci SD; Gonzales AJ; Resta TC; Walker BR
    Am J Physiol Heart Circ Physiol; 2011 Oct; 301(4):H1331-40. PubMed ID: 21841016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasopressin vs. terlipressin in the treatment of cardiovascular failure in sepsis.
    Lange M; Ertmer C; Westphal M
    Intensive Care Med; 2008 May; 34(5):821-32. PubMed ID: 18066524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical review: Vasopressin and terlipressin in septic shock patients.
    Delmas A; Leone M; Rousseau S; Albanèse J; Martin C
    Crit Care; 2005 Apr; 9(2):212-22. PubMed ID: 15774080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison between haemodynamic effects of vasopressin analogues.
    Tabrizchi R; Ford CA
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Nov; 370(5):340-6. PubMed ID: 15526109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of vasopressin in the management of septic shock.
    Mutlu GM; Factor P
    Intensive Care Med; 2004 Jul; 30(7):1276-91. PubMed ID: 15103461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.